26 EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMISED CONTROLLED TRIAL

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial

American Journal of Transplantation ◽

10.1111/j.1600-6143.2012.04212.x ◽

2012 ◽

Vol 12 (11) ◽

pp. 3008-3020 ◽

Cited By ~ 198

Author(s):

P. De Simone ◽

F. Nevens ◽

L. De Carlis ◽

H. J. Metselaar ◽

S. Beckebaum ◽

...

Keyword(s):

Renal Function ◽

Liver Transplant ◽

De Novo ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-015-0626-0 ◽

2015 ◽

Vol 16 (1) ◽

Cited By ~ 8

Author(s):

Bjorn Nashan ◽

Peter Schemmer ◽

Felix Braun ◽

Markus Dworak ◽

Peter Wimmer ◽

...

Keyword(s):

Renal Function ◽

Liver Transplant ◽

Study Protocol ◽

De Novo ◽

Controlled Trial ◽

Early Initiation ◽

Transplant Recipients ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955076.793461374 ◽

2012 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Renal Function ◽

Liver Transplant ◽

De Novo ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

Randomised controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid

http://isrctn.org/> ◽

10.1186/isrctn16781831 ◽

2012 ◽

Author(s):

Ghent Cam

Keyword(s):

Randomised Controlled Trial ◽

Liver Transplant ◽

Ursodeoxycholic Acid ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomised Controlled ◽

A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipients

Gut ◽

10.1136/gut.2006.107862 ◽

2007 ◽

Vol 56 (2) ◽

pp. 304-306 ◽

Cited By ~ 16

Author(s):

N Assy ◽

P C Adams ◽

P Myers ◽

V Simon ◽

C N Ghent

Keyword(s):

Randomised Controlled Trial ◽

Liver Transplant ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomised Controlled ◽

Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients

Transplantation Journal ◽

10.1097/tp.0000000000001524 ◽

2017 ◽

Vol 101 (2) ◽

pp. 341-349 ◽

Cited By ~ 4

Author(s):

William C. Chapman ◽

Robert S. Brown ◽

Kenneth D. Chavin ◽

Debra Sudan ◽

Baburao Koneru ◽

...

Keyword(s):

Renal Function ◽

Liver Transplant ◽

De Novo ◽

Transplant Recipients ◽

Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study

BMC Nephrology ◽

10.1186/1471-2369-11-24 ◽

2010 ◽

Vol 11 (1) ◽

Cited By ~ 8

Author(s):

Andreas A Schnitzbauer ◽

Marcus N Scherer ◽

Justine Rochon ◽

Johannes Sothmann ◽

Stefan A Farkas ◽

...

Keyword(s):

Renal Function ◽

Pilot Study ◽

Liver Transplant ◽

Study Protocol ◽

Impaired Renal Function ◽

De Novo ◽

Transplant Recipients ◽

Mtor Inhibition ◽

Safety And Efficacy ◽

180 EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL

Journal of Hepatology ◽

10.1016/s0168-8278(13)60182-8 ◽

2013 ◽

Vol 58 ◽

pp. S79-S80 ◽

Cited By ~ 2

Author(s):

F. Saliba ◽

H.J. Metselaar ◽

S. Beckebaum ◽

C. Duvoux ◽

M. Navasa ◽

...

Keyword(s):

Liver Transplant ◽

De Novo ◽

Controlled Trial ◽

Transplant Recipients ◽

Randomized Controlled ◽

Impact on Renal Function of Stepwise Withdrawal of Tacrolimus Combined with Everolimus and EC-MPS vs Standard Treatment Combining Tacrolimus and EC-MPS in De Novo Liver Transplant Recipients: Results of the Simcer Study

Journal of Hepatology ◽

10.1016/s0168-8278(16)00048-9 ◽

2016 ◽

Vol 64 (2) ◽

pp. S152-S153

Author(s):

F. Conti ◽

F. Saliba ◽

C. Duvoux ◽

S. Dharancy ◽

J. Dumortier ◽

...

Keyword(s):

Renal Function ◽

Liver Transplant ◽

Standard Treatment ◽

De Novo ◽

Transplant Recipients ◽

Impact of Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus on the Evolution of Renal Function in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study

Transplantation Journal ◽

10.1097/00007890-201211271-00080 ◽

2012 ◽

Vol 94 (10S) ◽

pp. 44 ◽

Cited By ~ 1

Author(s):

H. J. Metselaar ◽

F. Saliba ◽

P. Schemmer ◽

D. Foltys ◽

J. Fabregat ◽

...

Keyword(s):

Renal Function ◽

Liver Transplant ◽

De Novo ◽

Transplant Recipients ◽